This paper gives background on designing vaccines to maximize rapid antibody responses post-infection, ideally before the virus enters cells:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936610/
-
This paper talks about how this is achieved specifically for SARS-CoV-2:
https://www.biorxiv.org/content/10.1101/2020.06.15.152835v1....